Latest filing published 03 Nov 2020 for BioCardia, Inc., €15k.
Filing timeline
BuySaleInsider track record
Eric Duckers: trading record in brief
All filings by Eric Duckers on record concern BioCardia, Inc. Between 6 August 2019 and 2 November 2020, the trades on record add up to 6 filings.
Every open-market trade on record is a sale: 1 sale worth €15k. Besides market trades, the filings include 4 share grants. So far in 2020, the count stands at no purchases and 1 sale.
The newest entry dates from 3 November 2020: an open-market sale of €15k, in BioCardia, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Eric Duckers
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,435 shares@ US$2.0143.2% of flowCommon StockSEC:0001437749-20-022418:0
- 7,154 shares@ US$2.4045.4% of flowCommon StockSEC:0001437749-20-014424:0
- 17,500 shares0Common StockSEC:0001437749-20-008734:0
- 1,205 shares@ US$3.606.8% of flowCommon StockSEC:0001437749-20-006393:1
- 2,947 shares0Common StockSEC:0001437749-20-006393:0
- 8,435 shares@ US$3.0040.1% of flowCommon StockSEC:0001437749-19-016066:0
6 of 6 declarations